yea - we don't know if there is any need for "stronger" version in our case whatsoever - we are not trying to cure staph, right? and we certainly don't want any excessive and unnecessary loading of our immune system.
I think this is right.
The way a vaccine normally works, which is to educate the adaptive immune system into making antibodies that target and neutralize certain components (antigens) of a microbe, may
not involved at all in the benefits this Staphylococcus vaccine has for ME/CFS.
Rather, I think it is more likely that the toxoid components in the vaccine are acting like therapeutic drugs in the body.
For example, at the bottom of
this post, you see how enterotoxin B in the vaccine acts like a drug on the CD28 receptor (the CD28 receptor controls differentiation of regulatory T-cells, which play a central role in autoimmunity, by maintaining immune self-tolerance)
And in
this post you see how purified staphylococcal toxoid seems to fix the immunosuppression caused by caused by coxsackievirus B, a virus strongly linked to ME/CFS.
So what does all this mean in terms of choosing the adsorbed or non-adsorbed version of the Russian Staphylococcus toxoid vaccine as an ME/CFS treatment?
Well, the adsorption is done onto aluminum hydroxide. Adsorption just involves "glueing" Staphylococcus antigens onto aluminum hydroxide.
In
this paper on aluminum hydroxide-adsorbed vaccines, it says:
The vaccines adsorbed on aluminium hydroxide as adjuvant were less toxic in laboratory tests, were more potent in laboratory tests, and were less reaction-provoking in children.
So this indicates that aluminum hydroxide-adsorbed vaccines are more potent because they generally produce a better education of the adaptive immune response; but since the adaptive immune response may or may not be involved in the benefits this Staphylococcus toxoid vaccine has for ME/CFS, this increase in potency may or may not be of benefit for ME/CFS.
Furthermore, if the Staphylococcus antigens (like alpha toxin and enterotoxin B toxoids) are "glued" to aluminum hydroxide via adsorption, could this actually
reduce the efficacy of these toxoids?
For example, if the vaccine works for ME/CFS because the enterotoxin B toxoid binds to the CD28 receptor, if enterotoxin B is "glued" to aluminum hydroxide, will enterotoxin B still be able to bind to the CD28 receptor as effectively?